Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker AKTS
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | Akos Czibere Chief Medical Officer | AKTS Aktis Oncology, Inc. | Sale | 7,401 | $21.03 | $155.6K Sale | Form 4 ↗ |
| Sep 23, 2026 | Akos Czibere Chief Medical Officer | AKTS Aktis Oncology, Inc. | Sale | 5,099 | $20.19 | $102.9K Sale | Form 4 ↗ |
| Jul 20, 2026 | Ken Herrmann Director | AKTS Aktis Oncology, Inc. | Sale | 1,350 | $24.56 | $33.2K Sale | Form 4 ↗ |
| Jul 20, 2026 | Ken Herrmann Director | AKTS Aktis Oncology, Inc. | Sale | 3,506 | $24.56 | $86.1K Sale | Form 4 ↗ |
| Jul 17, 2026 | Ken Herrmann Director | AKTS Aktis Oncology, Inc. | Sale | 3,065 | $25.21 | $77.3K Sale | Form 4 ↗ |
| Jul 8, 2026 | Ron-Bigger Shulamit Chief Operating Officer | AKTS Aktis Oncology, Inc. | Sale | 4,200 | $28.75 | $120.8K Sale | Form 4 ↗ |
| Jul 8, 2026 | Ron-Bigger Shulamit Chief Operating Officer | AKTS Aktis Oncology, Inc. | Sale | 30,000 | $27.94 | $838.2K Sale | Form 4 ↗ |
| Jul 8, 2026 | Ron-Bigger Shulamit Chief Operating Officer | AKTS Aktis Oncology, Inc. | Sale | 15,800 | $27.13 | $428.7K Sale | Form 4 ↗ |
| Jul 8, 2026 | Akos Czibere Chief Medical Officer | AKTS Aktis Oncology, Inc. | Sale | 4,371 | $28.71 | $125.5K Sale | Form 4 ↗ |
| Jul 8, 2026 | Akos Czibere Chief Medical Officer | AKTS Aktis Oncology, Inc. | Sale | 30,829 | $27.95 | $861.7K Sale | Form 4 ↗ |
| Jul 8, 2026 | Akos Czibere Chief Medical Officer | AKTS Aktis Oncology, Inc. | Sale | 14,800 | $27.13 | $401.5K Sale | Form 4 ↗ |
| Jan 12, 2026 | Todd Foley Director, 10% owner | AKTS Aktis Oncology, Inc. | Buy | 232,870 | $18.00 | $4.2M Buy | Form 4 ↗ |
| Jan 12, 2026 | MPM Oncology Innovations Fund LP 10% owner | AKTS Aktis Oncology, Inc. | Buy | 1.11M | $18.00 | $20.0M Buy | Form 4 ↗ |
| Jan 12, 2026 | Ansbert Gadicke 10% owner | AKTS Aktis Oncology, Inc. | Buy | 1.11M | $18.00 | $20.0M Buy | Form 4 ↗ |
| Jan 12, 2026 | Vida Ventures II-A, LLC 10% owner | AKTS Aktis Oncology, Inc. | Buy | 22,545 | $18.00 | $405.8K Buy | Form 4 ↗ |
| Jan 12, 2026 | Vida Ventures II-A, LLC 10% owner | AKTS Aktis Oncology, Inc. | Buy | 812,455 | $18.00 | $14.6M Buy | Form 4 ↗ |
| Jan 12, 2026 | Helen Susan Kim Director, 10% owner | AKTS Aktis Oncology, Inc. | Buy | 22,545 | $18.00 | $405.8K Buy | Form 4 ↗ |
| Jan 12, 2026 | Helen Susan Kim Director, 10% owner | AKTS Aktis Oncology, Inc. | Buy | 812,455 | $18.00 | $14.6M Buy | Form 4 ↗ |
| Jan 12, 2026 | Oleg Nodelman Director | AKTS Aktis Oncology, Inc. | Buy | 144,443 | $18.00 | $2.6M Buy | Form 4 ↗ |
| Jan 12, 2026 | Oleg Nodelman Director | AKTS Aktis Oncology, Inc. | Buy | 2.08M | $18.00 | $37.4M Buy | Form 4 ↗ |
20 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:42 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances